| Revenue growth | FY26 GWP grew 16% YoY; Fresh retail growth 37% YoY. |
|---|---|
| Margins | Combined ratio improved to 98.8% in FY26 from 101.1% in FY25. |
| Demand visibility | Strong; Retail Health outpacing broader non-life industry growth. |
| Management confidence | High confidence in disciplined execution and risk-first balance of growth/ROE. |
Growth
FY26 PAT grew 16% YoY to ₹911 Cr. Q4 FY26 GWP increased 17% YoY to ₹6,259 Cr.
Outlook
Targeting 1 million agents in 2 years; focus on mid-to-high teen ROE and sustainable high-teen growth.
Risks
Mark-to-market equity losses of ₹558 Cr in Q4; potential seasonal claims recurrence in FY27.
Earnings Call filed with NSE, NSE: STARHEALTH. Summary written with AI assistance from the document.
Star Health and Allied Insurance Company Ltd: key numbers
- Share price
- ₹558.15
- Market cap
- ₹32,801 Cr
- Revenue (annual)
- ₹17,825 Cr
- Net profit (annual)
- ₹557.0 Cr
- P/E (TTM)
- 38.9×Sector 22.0×
- Promoter holding
- 58.01%+0.03% QoQ
- FII holding
- 16.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Health and Allied Insurance Company Ltd
All →Star Health and Allied Insurance Company Board Meeting Date
Star Health and Allied Insurance Company Ltd has scheduled a board meeting on October 27, 2026, to approve its quarterly and half-yearly financial results.
Star Health and Allied Insurance Company Promoter Reclassification
Star Health has withdrawn its application for reclassification of three promoter group entities. The Board of Directors approved this withdrawal via circular resolution.
Star Health and Allied Insurance Company Other Announcement
Star Health has withdrawn its reclassification application for IDC Electronics Limited, a promoter group entity. Entities that have ceased to exist are also removed from promoter group.
Star Health and Allied Insurance Company Earnings Call Transcript: Key Takeaways
Star Health delivered strong Q1 FY27 results with GWP growing 19% YoY to ₹4,287 Cr and PAT rising 25% to ₹550 Cr. Strategy focuses on proprietary distribution and underwriting profitability.
Star Health and Allied Insurance Company Investor Presentation: Key Takeaways
Star Health Q1 FY27 results show strong underwriting profitability and a 25% YoY PAT increase. Strategy focuses on proprietary distribution, retail health leadership, and digital/AI-driven claims precision.
- Call
- Guides 16% growth
Star Health and Allied Insurance Company Earnings Call Transcript: Key Takeaways
Star Health marked its 20th anniversary with strong Q1 FY27 results, showing 19% GWP growth and consistent underwriting profitability despite a higher claims season.
- Call
- Guides 16% growth